<DOC>
	<DOCNO>NCT01496950</DOCNO>
	<brief_summary>The purpose study determine whether active repetitive transcranial magnetic stimulation leave dorsolateral prefrontal cortex safe effective preventive treatment chronic migraine , compare placebo repetitive transcranial magnetic stimulation .</brief_summary>
	<brief_title>Double-blind Randomized Clinical Trial Transcranial Magnetic Stimulation Chronic Migraine</brief_title>
	<detailed_description>Patients chronic migraine accord criterion International Headache Society randomize either active repetitive transcranial magnetic stimulation leave dorsolateral prefrontal cortex placebo repetitive transcranial magnetic stimulation , total 23 session treatment ( 15 session first month 8 session second month treatment ) . Outcomes evaluated baseline , one , two month treatment , one month end treatment</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>chronic migraine accord criterion International Headache Society change prophylactic medication past 3 month neurological disorder bipolar disorder alcohol drug dependence past 2 month suicidal ideation , psychotic symptom contraindication transcranial magnetic stimulation ( cardiac pacemaker , implant electronic device , metal skull , skull fracture , history seizure ) use antidepressant past 4 week pregnancy lack birthcontrol method woman childbearing age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>migraine</keyword>
</DOC>